Anixa Biosciences, Inc. (ANIX) Stock Overview
Explore Anixa Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Anixa Biosciences, Inc. (ANIX)
Key Financials
Key Financials
Market Cap
119.8M
P/E Ratio
-11.38
EPS (TTM)
$-0.31
ROE
-0.66%
ANIX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Anixa Biosciences, Inc. (NASDAQ: ANIX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Anixa Biosciences, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ANIX on the NASDAQ shows an RSI of 59.66, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $2.77 for the NASDAQ listing.
Key metrics behind Anixa Biosciences, Inc.'s NASDAQ-traded stock include a P/E ratio of -11.38 and a market capitalization of 119.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ANIX on the NASDAQ.